Literature DB >> 10523650

p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.

E G Reynaud1, K Pelpel, M Guillier, M P Leibovitch, S A Leibovitch.   

Abstract

We show that expression of p57(Kip2), a potent tight-binding inhibitor of several G(1) cyclin-cyclin-dependent kinase (Cdk) complexes, increases markedly during C2C12 myoblast differentiation. We examined the effect of p57(Kip2) on the activity of the transcription factor MyoD. In transient transfection assays, transcriptional transactivation of the mouse muscle creatine kinase promoter by MyoD was enhanced by the Cdk inhibitors. In addition, p57(Kip2), p21(Cip1), and p27(Kip1) but not p16(Ink4a) induced an increased level of MyoD protein, and we show that MyoD, an unstable nuclear protein, was stabilized by p57(Kip2). Forced expression of p57(Kip2) correlated with hypophosphorylation of MyoD in C2C12 myoblasts. A dominant-negative Cdk2 mutant arrested cells at the G(1) phase transition and induced hypophosphorylation of MyoD. Furthermore, phosphorylation of MyoD by purified cyclin E-Cdk2 complexes was inhibited by p57(Kip2). In addition, the NH2 domain of p57(Kip2) necessary for inhibition of cyclin E-Cdk2 activity was sufficient to inhibit MyoD phosphorylation and to stabilize it, leading to its accumulation in proliferative myoblasts. Taken together, our data suggest that repression of cyclin E-Cdk2-mediated phosphorylation of MyoD by p57(Kip2) could play an important role in the accumulation of MyoD at the onset of myoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523650      PMCID: PMC84790          DOI: 10.1128/MCB.19.11.7621

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation.

Authors:  R Eckner; T P Yao; E Oldread; D M Livingston
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

Review 2.  Cdk inhibitors in development and cancer.

Authors:  J W Harper; S J Elledge
Journal:  Curr Opin Genet Dev       Date:  1996-02       Impact factor: 5.578

3.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.

Authors:  A A Russo; P D Jeffrey; A K Patten; J Massagué; N P Pavletich
Journal:  Nature       Date:  1996-07-25       Impact factor: 49.962

Review 4.  Why are there so many CDK inhibitors?

Authors:  Y Xiong
Journal:  Biochim Biophys Acta       Date:  1996-08-08

Review 5.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

6.  MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation.

Authors:  K Guo; J Wang; V Andrés; R C Smith; K Walsh
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

7.  Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F.

Authors:  K Guo; K Walsh
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

Review 8.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

9.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.

Authors:  S Matsuoka; M C Edwards; C Bai; S Parker; P Zhang; A Baldini; J W Harper; S J Elledge
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

10.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Authors:  O Boussif; F Lezoualc'h; M A Zanta; M D Mergny; D Scherman; B Demeneix; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  33 in total

1.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  p27Kip1 acts downstream of N-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation.

Authors:  Graziella Messina; Cristiana Blasi; Severina Anna La Rocca; Monica Pompili; Attilio Calconi; Milena Grossi
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

3.  PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.

Authors:  Wendy Roeb; Antonia Boyer; Webster K Cavenee; Karen C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

Review 4.  MicroRNAs regulate and provide robustness to the myogenic transcriptional network.

Authors:  Jeffrey Gagan; Bijan K Dey; Anindya Dutta
Journal:  Curr Opin Pharmacol       Date:  2012-03-02       Impact factor: 5.547

Review 5.  Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective.

Authors:  T G Mainprize; M D Taylor; J T Rutka; P B Dirks
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

6.  CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P.

Authors:  Partha Mitra; Prachi N Ghule; Margaretha van der Deen; Ricardo Medina; Rong-Lin Xie; William F Holmes; Xin Ye; Keiichi I Nakayama; J Wade Harper; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

7.  Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation.

Authors:  Weizhen Ye; Georges Mairet-Coello; Elise Pasoreck; Emanuel Dicicco-Bloom
Journal:  Dev Neurobiol       Date:  2009-01       Impact factor: 3.964

8.  A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation.

Authors:  Minsoo Kim; Takashi Nakamoto; Shigeki Nishimori; Keiji Tanaka; Tomoki Chiba
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

9.  Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model.

Authors:  Etsuo Susaki; Keiko Nakayama; Lili Yamasaki; Keiichi I Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-10       Impact factor: 11.205

10.  p57(Kip2) cooperates with Nurr1 in developing dopamine cells.

Authors:  Bertrand Joseph; Asa Wallén-Mackenzie; Gérard Benoit; Takashi Murata; Eliza Joodmardi; Sam Okret; Thomas Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.